India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#194- Valuation
- ₹31,580 Cr
2023 #179 2022 #171 2021 #180
Revenue · FY 2025
₹16,537 Cr
▲ 13% YoY
Net profit · FY 2025
₹1,856.19 Cr
Net margin 11.2%
EBITDA · FY 2025
₹3,044.66 Cr
EBITDA margin 18.4%
Authorised capital
₹320 Cr
Registered with MCA
Paid-up capital
₹277.06 Cr
Issued & subscribed
Open charges
₹6,736.19 Cr
Satisfied ₹13,851 Cr
Company age
37 yrs
Est. 1989
Employees · EPFO
7,319
Provident fund records
About Hetero Labs Limited
Data last updated:
Hetero Labs Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 March 1989 and has been in existence for over 37 years.
Its director B Parthasaradhi Reddy and family are #70 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG1989PLC009723. Its GSTIN is 36AAACH5506R1Z8 (Telangana). The company holds 19 GST registrations, of which 14 are active.
The company has an authorised share capital of ₹320 Cr and a paid-up capital of ₹277.06 Cr. It was formerly known as Permila Drugs Private Limited and Hetero Drugs Private Limited. It is led by directors including Bandi Vamsikrishna (Managing Director) and Attunuri Venkatanarasa Reddy (Whole-Time Director).
Its last annual general meeting (AGM) was held on 11 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹16,537 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹1,856.19 Cr (net margin 11.2%) and EBITDA of ₹3,044.66 Cr (EBITDA margin 18.4%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 15% over five years.
The company has about 7,319 employees on its provident fund (EPFO) records. Its group structure includes 14 subsidiaries.
The company is associated with 1 brand: Hetero. As per MCA filings, the company has open charges of ₹6,736.19 Cr and satisfied charges of ₹13,851 Cr on record. Court records list 202 cases involving the company, including 117 filed by the company and 86 filed against it; 64 cases are pending. The company has 5 deals on record (5 secondary share transfers); the latest was in September 2017. Its 9 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Aurobindo Pharma Ltd with revenue of ₹32,346 Cr. The company has 45 MSME Form 1 returns on record between 2016 and 2024, listing 4,498 overdue payments to 345 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hetero.com.
Company details
CIN U24110TG1989PLC009723
Registration Number 009723
Incorporation Date 10 March 1989
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Name history
Hetero Labs has undergone 3 name changes throughout its history. The company was previously known as Permila Drugs Private Limited, Hetero Drugs Private Limited, and Pharmasia Laboratory Private Limited. The current legal name is Hetero Labs Limited.
| Company Name | Status |
|---|---|
| Hetero Labs Limited | Current |
| Permila Drugs Private Limited | Previous |
| Hetero Drugs Private Limited | Previous |
| Pharmasia Laboratory Private Limited | Previous |
CIN history
Hetero Labs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24110TG1989PLC009723, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110TG1989PLC009723 | Current |
| U24110AP1989PLC009723 | Previous |
| L24110AP1989PLC009723 | Previous |
Key People
Bandi Vamsikrishna Managing Director Attunuri Venkatanarasa Reddy Whole-Time Director Mohana Reddy Chilukuri Whole-Time Director Recognitions & Rankings of Hetero Labs
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #70 B Parthasaradhi Reddy & family ₹39,400 Cr
Contact details
Hetero Labs Limited's registered office is in Hyderabad, Telangana. Its website is hetero.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address#7 – 2 – A2, Industrial Estate Sanath Nagar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Hetero Labs Limited, buy the company report.
Comprehensive company report
Hetero Labs Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hetero Labs operates one associated brand: Hetero. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Hetero is recognized as a leading global pharmaceutical company based in India. | hetero.com |
Business activity
The main business activity of Hetero Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hetero Labs Limited, buy the company report.
Financials of Hetero Labs Limited
FY 2025 filings availableHetero Labs Limited reported revenue of ₹16,537 Cr (up 13% YoY) for FY 2025.
Revenue · FY 2025
₹16,537 Cr ▲ 13%
Net profit · FY 2025
₹1,856.19 Cr margin 11.2%
EBITDA · FY 2025
₹3,044.66 Cr margin 18.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 11%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 16%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 13% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,044.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,856.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.4% | ||||
| Net Profit Margin | 11.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hetero Labs Limited, buy the company report.
Board of directors of Hetero Labs Limited
Hetero Labs has 7 current directors and 22 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bandi Vamsikrishna Also directs: Allita Finvest and Advisors LLP, Eliana Investments and Holdings LLP, Krishn Capital Advisors LLP and 5 more | Managing Director | 10 Apr 2008 | 18 Years 6 Months | Current |
| Govindaraju Bhavani Also directs: Hetero Biopharma Limited, Annora Pharma Private Limited | Director | 11 Aug 2023 | 3 Years 2 Months | Current |
| Parthasaradhi Reddy Bandi Also directs: Allita Finvest and Advisors LLP, Eliana Investments and Holdings LLP, Krishn Capital Advisors LLP and 5 more | Director | 01 Apr 2021 | 5 Years 6 Months | Current |
| Srinivas Reddy Male Also directs: Krishna Sahithi Reddy Properties LLP, Krishna Karthikeya Reddy Properties LLP, HHC Pharma LLP and 5 more | Director | 25 Sep 2008 | 18 Years 1 Months | Current |
| Attunuri Venkatanarasa Reddy Also directs: Hetero Drugs Limited | Whole-Time Director | 02 Jun 2014 | 12 Years 4 Months | Current |
| Sujesh Vasudevan | Director | 22 Feb 2024 | 2 Years 8 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Hetero Labs Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | ₹32,346 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Cipla Limited | ₹28,409 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Zydus Lifesciences Limited | ₹23,511 Cr (FY 2025) | 19.0% | Ahmedabad, Gujarat, India | |||
| Lupin Limited | ₹22,904 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Intas Pharmaceuticals Limited | ₹21,241 Cr (FY 2025) | 7.0% | Ahmedabad, Gujarat, India | |||
| Hetero Labs Limitedthis company | ₹16,537 Cr (FY 2025) | ₹1,856.19 Cr | 11.2% | 13.0% | 7,319 | Hyderabad, Telangana, India |
| Biocon Limited | ₹16,470 Cr (FY 2025) | 5.0% | Bengaluru, Karnataka, India | |||
| Alkem Laboratories Limited | ₹13,458 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Glenmark Pharmaceuticals Limited | ₹13,435 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Torrent Pharmaceuticals Ltd | ₹11,539 Cr (FY 2025) | 7.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Hetero Labs Limited, buy the company report.
Auditor
Hetero Labs Limited is audited by M.V.Narayana Reddy & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.V.Narayana Reddy & Co. | FY 2023 | 002370S |
Shareholding
The shareholding of Hetero Labs Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hetero Labs Limited, buy the company report.
Charges & borrowings
Open charges
₹6,736.19 Cr
Satisfied charges
₹13,851 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2026 | 101238989 | Others | ₹30.22 Lakh | Open | |
| 23 Jan 2026 | 101235216 | Others | ₹15.14 Lakh | Open | |
| 31 Dec 2025 | 101224720 | Others | ₹9.8 Lakh | Open | |
| 30 Dec 2025 | 101222068 | Others | ₹64 Lakh | Open | |
| 20 Dec 2025 | 101224826 | Others | ₹20.16 Lakh | Open |
To see the full charge records of Hetero Labs Limited, buy the company report.
Total charge records: 169 View all charges
Deals & funding
Hetero Labs Limited has 5 deals on record (5 secondary share transfers); the latest was in September 2017.
Total deals
5
Secondary share transfers
5
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2017 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: M Krishna Sindhuri Trust & B.Partha Saradhi Reddy Seller: 3 individuals |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Aug 2014 | Secondary share transfer | Undisclosed | Buyer: M Krishna Sindhuri Trust & B.Partha Saradhi Reddy Seller: an individual |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Hetero Labs Limited has 202 court cases on record: 117 filed by Hetero Labs, 86 filed against it. 64 cases are pending and 138 are disposed.
Total cases
202
Filed by the company
117
Filed against the company
86
Pending
64
Disposed
138
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 109 | 49 | 35 |
| District courts | 87 | 33 | 28 |
| Supreme Court | 4 | 4 | 1 |
| NCLT | 2 | 0 | 0 |
Cases on record (5 of 202)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Court case (ITTA) | Filed against the company by Hetero Labs Limited and 1 other | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Centurion Laboratories Pvt. Ltd., Rep. by Mr. A. Vanarasidas Patel and 3 others | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Centurion Laboratories Pvt. Ltd., Rep. by Mr. A. Vanarasidas Patel | Pending |
| High Court, TELANGANA | Court case (ITTA) | Filed by the company against Hetero Labs Limited. | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. J.Duncan Healthcare Pvt. Ltd., Rep. by Alok Awadhesh Kumar and 4 others | Pending |
To see the full case history of Hetero Labs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Hetero Labs Limited was last rated by Care on 07 Dec 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 07 Dec 2021 |
To see the full credit ratings and regulatory alerts of Hetero Labs Limited, buy the company report.
MSME payment delays
Hetero Labs Limited has 45 MSME Form 1 returns on record between 2016 and 2024, listing 4,498 overdue payments to 345 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 345)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Durga Printing & Packaging | |||
| Sunlit Elements Private Limited | |||
| an individual supplier | |||
| BCD Travel India Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Hetero Labs Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Hetero Labs has 14 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
14
Subsidiary companies
1
Associated companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|
Employees & EPFO
Hetero Labs Limited has a workforce of 7,319 employees on its EPFO records as of Nov 20, 2024, across 7 active EPFO establishments.
Employee count
7,319
Active EPFO establishments
7
Employee growth
7.02%
GST
Hetero Labs has 19 GST registrations: 14 active and 5 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
19
Active
14
Cancelled / inactive
5
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACH5506R1Z8 | Telangana | Active | 01 Jul 2017 |
| 36AAACH5506R2Z7 | Telangana | Active | 11 Jul 2017 |
| 36AAACH5506R3Z6 | Telangana | Active | 04 Aug 2017 |
| 02AAACH5506R1ZJ | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hetero Labs Limited, buy the company report.
Recent activity
Hetero Labs Limited has 26 board changes on record since 1999: 10 appointments and 16 cessations. The latest: Kiran Kumar Manikwar was appointed as Company Secretary on 06 Feb 2025.
Charges
A charge with Others amounted to Rs. 0.30 Cr with Charge ID 101238989 was registered on 31 Jan 2026.
Charges
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 101235216 was registered on 23 Jan 2026.
Charges
A charge with Others amounted to Rs. 0.10 Cr with Charge ID 101224720 was registered on 31 Dec 2025.
Charges
A charge with Others amounted to Rs. 0.64 Cr with Charge ID 101222068 was registered on 30 Dec 2025.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 101224826 was registered on 20 Dec 2025.
Charges
A charge with Bank Of India amounted to Rs. 0.15 Cr with Charge ID 101184655 was registered on 14 Nov 2025.
Charges
A charge with Bank Of India amounted to Rs. 0.08 Cr with Charge ID 101184648 was registered on 30 Oct 2025.
Charges
A charge registered on 26 Aug 2025 via Charge ID 101152876 with Bank Of India was fully satisfied on 22 Oct 2025.
Charges
A charge with Bank Of India amounted to Rs. 0.07 Cr with Charge ID 101169568 was registered on 26 Sep 2025.
Charges
A charge with Bank Of India amounted to Rs. 0.17 Cr with Charge ID 101169471 was registered on 23 Sep 2025.
Charges
A charge with Bank Of India amounted to Rs. 0.10 Cr with Charge ID 101169323 was registered on 22 Sep 2025.
Charges
A charge with Bank Of India amounted to Rs. 0.09 Cr with Charge ID 101164947 was registered on 20 Sep 2025.
264 earlier events are in the company report.
News
Frequently asked questions
Hetero Labs is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 March 1989 (37+ years old) and is registered under CIN U24110TG1989PLC009723.
Hetero Labs has 7 current directors:
- Bandi Vamsikrishna - Managing Director
- Attunuri Venkatanarasa Reddy - Whole-Time Director
- Mohana Reddy Chilukuri - Whole-Time Director
- Govindaraju Bhavani - Director
- Parthasaradhi Reddy Bandi - Director
- Srinivas Reddy Male - Director
- Sujesh Vasudevan - Director
The latest financial statements of Hetero Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hetero Labs is 36AAACH5506R1Z8, registered in Telangana. The company has 19 GST registrations in all, of which 14 are active and 5 are cancelled or inactive. Other active GSTINs include 36AAACH5506R2Z7 (Telangana), 36AAACH5506R3Z6 (Telangana), 02AAACH5506R1ZJ (Himachal Pradesh).
The CIN (Corporate Identification Number) of Hetero Labs is U24110TG1989PLC009723. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hetero Labs has 202 court cases on record: 117 filed by the company and 86 filed against it. 64 are pending. Most are in the high courts.
Hetero Labs was incorporated on 10 March 1989, making it 37+ years old. It is registered with the Registrar of Companies, Hyderabad.
Hetero Labs has 5 deals on record (5 secondary share transfers); the latest was in September 2017.
The peers of Hetero Labs by revenue are Aurobindo Pharma Ltd, Cipla Limited, Zydus Lifesciences Limited, Lupin Limited, Intas Pharmaceuticals Limited and 4 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kiran Kumar Manikwar was appointed as Company Secretary on 06 Feb 2025. Sujesh Vasudevan ceased to be Additional Director on 29 Sep 2024. Sujesh Vasudevan was appointed as Director on 22 Feb 2024. Hetero Labs has 26 board changes on record in total.
Hetero Labs has 45 MSME Form 1 returns on record between 2016 and 2024, listing 4,498 overdue payments to 345 micro and small suppliers. The latest return was filed on 23 May 2024.
Hetero Labs can be reached through the website hetero.com. Its registered office is in Hyderabad, Telangana, India.